Erratum to: Application of next generation sequencing to CEPH cell lines to discover variants associated with FDA approved chemotherapeutics Public Deposited

Downloadable Content

Download PDF
Creator
  • Lam, Ernest T
    • Other Affiliation: Cardiovascular Research Institute, UCSF School of Medicine, San Francisco, CA, USA
  • Wagner, Michael J
    • Affiliation: Eshelman School of Pharmacy, Center of Pharmacogenomics and Individualized Therapy
  • McLeod, Howard L.
    • Affiliation: Eshelman School of Pharmacy, Center of Pharmacogenomics and Individualized Therapy
    • Other Affiliation: Moffitt Cancer Center, Tampa, FL, USA
  • Hariani, Gunjan D
    • Other Affiliation: Bioinformatics Research Center, North Carolina State University, 307 Ricks Hall, 1 Lampe Dr, 27695 CB7566 Raleigh, NC, USA
  • Motsinger-Reif, Alison A
    • Other Affiliation: Bioinformatics Research Center, North Carolina State University, 307 Ricks Hall, 1 Lampe Dr, 27695 CB7566 Raleigh, NC, USA; Department of Statistics, North Carolina State University, Raleigh, NC, USA
  • Havener, Tammy
    • Affiliation: Eshelman School of Pharmacy, Center of Pharmacogenomics and Individualized Therapy
  • Kwok, Pui-Yan
    • Other Affiliation: Cardiovascular Research Institute, UCSF School of Medicine, San Francisco, CA, USA
Abstract
  • After publication of this work [1], it has come to our attention that there is an error in the author list of the initial version of this manuscript; rather than Ernest J Lam, the second author of the manuscript should be listed as Ernest T Lam.
Date of publication
Identifier
  • doi:10.1186/1756-0500-7-652
Resource type
  • Journal Item
Rights statement
  • In Copyright
Rights holder
  • Hariani et al.; licensee BioMed Central Ltd.
Language
  • English
Bibliographic citation
  • BMC Research Notes. 2014 Sep 17;7(1):652
Publisher
  • BioMed Central
Parents:

This work has no parents.

Items